Concepta PLC (LSE:CPT) - Share price - Overview

Stock Report

Concepta PLC CPT

Last Price
GBX6.75

Day Change
-0.25|-3.57%

As of 22/01/2018
16:24:05 GMT | GBX
Minimum 15 Minutes Delay.

Last Close7.00p
Day Range6.62 - 6.92
Mkt Cap9.33Mil
52-Wk Range6.15 - 19.20
Yield %0.00
ISINGB00BYZ2R301
Volume185,522
P/E-2.09
P/SInfinity
P/CF-4.50

Share Price

Total Returns 22/01/2018

 Chg (%)  
More ...
Concepta PLC1.89 
FTSE 100 TR GBP1.74
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-0.52-0.16-2.79
Net Profit-0.52-0.17-2.63
Reported EPS-98.00-16.75-3.27
Balance Sheet
Current Assets0.140.073.09
Non Current Assets1.940.000.40
Total Assets2.070.543.49
Current Liabilities0.700.630.18
Total Liabilities0.700.630.18
Total Equity1.38-0.093.31
Cash Flow
Operating Cash Flow-0.29-0.33-1.60
Net Change in Cash-0.10-0.082.84
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Regulatory News

DateSourceHeadline
More ...
02/01/2018|12:52RNSConcepta PLC - Change of Broker
22/12/2017|11:30RNSConcepta PLC - Trading update
30/11/2017|15:05RNSConcepta PLC - Director/PDMR Shareholding
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/11/2017PurchaseErik Henau7.80100,0007,800.00
22/06/2017PurchaseErik Henau12.1880,0009,740.00

Company Profile

Concepta PLC is engaged in health diagnostics for women's fertility and specifically unexplained infertility. Concepta's portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.

Sector

Medical Devices

Market Position

1530 of 1835 Companies

Index

FTSE AIM All Share

Outlook

(06/11/2017) "...revenues from this expected order will be realised in Q1 2018, meaning that 2017 revenues will be lower than market expectations"

Next Event 26/04/2018

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)0.0019.965.53
Div Yld (E)0.001.574.03
PEG (E)0.001.750.98
ROCE-89.0018.35180.33
Op Mrgn0.007.77-126.27
EPS Grwth0.0020.1122.39
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Adam Reynolds
Chief Executive OfficerErik Henau
Finance Director & Company SecretaryMrs. Barbara Spurrier
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.